ABBOTT LABORATORIES
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
ABT$109.93-3.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Valuation and Qualifying Accounts (Schedule II)
ABBOTT LABORATORIES AND SUBSIDIARIES
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021
| Allowances for DoubtfulAccounts and Product Returns | Balanceat Beginningof Year | Provisions/Chargesto Income | AmountsCharged Offand OtherDeductions | Balance atEnd of Year |
|---|---|---|---|---|
| 2023 | $500 | $60 | $(116) | $444 |
| 2022 | 519 | 122 | (141) | 500 |
| 2021 | 460 | 145 | (86) | 519 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.